Reversal of inflammation‐associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22402PMID 17266043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of flavones from the roots of Scutellaria baicalensis with the benzodiazepine site.

  2009cited by this paper
• Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma.

  2006cited by this paper
• Expression of dihydrodiol dehydrogenase and resistance to chemotherapy and radiotherapy in adenocarcinoma cells of lung.

  2006cited by this paper
• Characterization of Chemical Constituents in Scutellaria baicalensis with Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma

  2005cited by this paper
• Chrysin suppresses lipopolysaccharide‐induced cyclooxygenase‐2 expression through the inhibition of nuclear factor for IL‐6 (NF‐IL6) DNA‐binding activity

  2005cited by this paper
• Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.

  2005cited by this paper
• Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex

  2004cited by this paper
• Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins

  2004cited by this paper
• Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins.

  2004cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Interleukin‐6 is responsible for drug resistance and anti‐apoptotic effects in prostatic cancer cells

  2004cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Evaluation of Combination Chemotherapy

  2004cited by this paper
• Crystal structure of human prostaglandin F synthase (AKR1C3).

  2004cited by this paper
• At the crossroads of inflammation and cancer.

  2004cited by this paper
• Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase

  2004cited by this paper
• Inverse expression of dihydrodiol dehydrogenase and glutathione‐S‐transferase in patients with esophageal squamous cell carcinoma

  2004influential reference
• Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.

  2003cited by this paper
• Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma.

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Cyclooxygenase-2 in human non-small cell lung cancer.

  2003cited by this paper
• Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex

  2003cited by this paper
• Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line.

  2003cited by this paper
• Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism

  2003cited by this paper
• Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

  2003cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Effects of Platelet Activating Factor, Butyrate and Interleukin-6 on Cyclooxygenase-2 Expression in Human Esophageal Cancer Cells

  2002cited by this paper
• Protein Kinase C δ Associates with the Interleukin-6 Receptor Subunit Glycoprotein (gp) 130 via Stat3 and Enhances Stat3-gp130 Interaction*

  2002cited by this paper
• Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells*

  2002cited by this paper
• Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.

  2002cited by this paper
• Antioxidant and antiradical activities of flavonoids.

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.

  2001cited by this paper
• Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator‐activated receptor‐γ by flavonoids in mouse macrophages

  2001cited by this paper
• Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.

  2001cited by this paper
• Wogonin inhibits inducible prostaglandin E(2) production in macrophages.

  2000cited by this paper
• Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2.

  2000cited by this paper
• Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis

  2000cited by this paper
• Transcriptional Regulation of the Antioxidant Response Element

  2000cited by this paper
• Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate

  1999cited by this paper
• Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.

  1999cited by this paper
• Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships.

  1999cited by this paper
• Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.

  1997cited by this paper
• Signaling mechanisms through gp130: a model of the cytokine system.

  1997cited by this paper
• Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells.

  1996cited by this paper
• The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin.

  1996cited by this paper
• Cytokine signal transduction.

  1995cited by this paper
• Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics.

  1994cited by this paper
• Cytokine signal transduction.

  1994cited by this paper
• Overproduction of a 37.5-kDa cytosolic protein structurally related to prostaglandin F synthase in ethacrynic acid-resistant human colon cells.

  1993cited by this paper
• Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase.

  1993cited by this paper
• Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism.

  1993cited by this paper
• Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver.

  1990cited by this paper
• Pharmacology of adriamycin: the message to the clinician.

  1988cited by this paper
• Studies on Scutellariae radix. Part II: The antibacterial substance.

  1981cited by this paper
• Studies on Scutellariae Radix

  1981cited by this paper
• [Inflammation and cancer].

  1974cited by this paper

• AKR1C2 silencing promotes ferroptosis and inhibits proliferation, migration, and invasion in lung cancer cells

  2025cites this paper
• Sophora compounds against non-small cell lung cancer: Research status and mechanisms.

  2025cites this paper
• Wogonin inhibits radiation-induced DNA damage repair in hepatocellular carcinoma cells by upregulating p21

  2025cites this paper
• Network pharmacology unveils the intricate molecular landscape of Chrysin in breast cancer therapeutics

  2025cites this paper
• Zingiberensis new saponin reverses sorafenib resistance by targeting lncRNA TCONS-00026762/AKR1C1 and modulating autophagy and ferroptosis in hepatocellular carcinoma.

  2025cites this paper
• Role of Aldo-Keto reductase family 1 member C in cancer progression: a special focus on the role of AKR1C1 in pancreatic cancer

  2025cites this paper
• Anticancer flavonoids producing endophytic fungi: A review

  2024cites this paper
• Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

  2024cites this paper
• Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes

  2024cites this paper
• GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation.

  2024cites this paper
• Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism

  2023cites this paper
• Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer

  2023cites this paper
• Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma

  2022cites this paper
• Wogonin and its analogs for the prevention and treatment of cancer: A systematic review

  2022influential citation
• Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer

  2022cites this paper
• Label-Free Profiling of up to 200 Single-Cell Proteomes per Day Using a Dual-Column Nanoflow Liquid Chromatography Platform.

  2022cites this paper
• The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking

  2022cites this paper
• Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line

  2022cites this paper
• Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study

  2022cites this paper
• RNA m6A methyltransferase METTL14 promotes the procession of non‐small cell lung cancer by targeted CSF1R

  2022cites this paper
• Chrysin sensitizes osteosarcoma cells against TRAIL‐induced apoptosis

  2022cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance and Epigenetic Regulation of the Nuclear Factor-Erythroid 2 p45-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Pathway Mediated by Aldo-Keto of Nuclear Factor-Erythroid 2 p45-Related Factor 2 and AKR Inhibitors to Surmount

  2021influential citation
• A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro

  2021cites this paper
• Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy.

  2021cites this paper
• Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer

  2021cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance

  2021influential citation
• Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

  2021cites this paper
• Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin

  2021cites this paper
• Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors.

  2021cites this paper
• Prognostic significance of ferroptosis-related genes and their methylation in AML

  2021cites this paper
• Aldo-Keto Reductases and Cancer Drug Resistance and Epigenetic Regulation of the Nuclear Factor-Erythroid 2 p45-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Pathway Mediated by Aldo-Keto of Nuclear Factor-Erythroid 2 p45-Related Factor 2 and AKR Inhibitors to Surmount

  2021influential citation
• Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.

  2020cites this paper
• Fascinating chemo preventive story of wogonin: A chance to hit on the head in cancer treatment.

  2020cites this paper
• Integrated data analysis reveals significant associations of KEAP1 mutations with DNA methylation alterations in lung adenocarcinomas

  2020cites this paper
• Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin

  2020cites this paper
• Gene Expression Classification of Lung Adenocarcinoma into Molecular Subtypes

  2020cites this paper
• The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer

  2020cites this paper
• Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy.

  2020cites this paper
• Human lung epithelial cells cultured in the presence of radon-emitting rock experience gene expression changes similar to those associated with tobacco smoke exposure.

  2019cites this paper
• avasimibe inhibits tumor growth by targeting FoxM1-aKr1c1 in osteosarcoma

  2019cites this paper
• Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism

  2019cites this paper
• Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids

  2019influential citation
• Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

  2019cites this paper
• Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

  2019cites this paper
• University of Birmingham Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma

  2018cites this paper
• Chrysin: A Promising Anticancer Agent its Current Trends and Future Perspectives

  2018cites this paper
• A Novel Systems Pharmacology Method to Investigate Molecular Mechanisms of Scutellaria barbata D. Don for Non-small Cell Lung Cancer

  2018cites this paper
• Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma

  2018cites this paper
• Wogonin affects proliferation and the energy metabolism of SGC-7901 and A549 cells.

  2018cites this paper
• AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer

  2018cites this paper
• Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-survivin pathway.

  2017cites this paper
• Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways.

  2017cites this paper
• Emodin: One Main Ingredient of Shufeng Jiedu Capsule Reverses Chemoresistance of Lung Cancer Cells Through Inhibition of EMT

  2017cites this paper
• The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial

  2017cites this paper
• Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.

  2017cites this paper
• High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells

  2016influential citation
• high expression of aKr 1 C 1 is associated with proliferation and migration of small-cell lung cancer cells

  2016influential citation
• Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway

  2016cites this paper
• Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells

  2016cites this paper
• Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance.

  2016cites this paper
• Suppression of the TNF‐alpha level is mediated by Gan‐Lu‐Yin (traditional Chinese medicine) in human oral cancer cells through the NF‐kappa B, AKT, and ERK‐dependent pathways

  2016cites this paper
• Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis ( Review )

  2016cites this paper
• Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis.

  2016cites this paper
• Mimicking postmenopausal steroid metabolism in breast cancer cell culture: Differences in response to DHEA or other steroids as hormone sources.

  2016cites this paper
• Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer

  2016cites this paper
• Identification and function analysis of contrary genes in Dupuytren's contracture.

  2015cites this paper
• Chrysin and its emerging role in cancer drug resistance.

  2015cites this paper
• Molecular histology of lung cancer: from targets to treatments.

  2015cites this paper
• Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives.

  2015cites this paper
• Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.

  2014cites this paper
• Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.

  2014cites this paper
• Characterization of mTOR Inhibition and Autophagy Inhibition in Non-Small Cell Lung Cancer

  2014cites this paper
• Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response

  2013cites this paper
• Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers.

  2013cites this paper
• Anti-tumor activity evaluation of novel chrysin-organogermanium(IV) complex in MCF-7 cells.

  2013cites this paper
• LKB 1 / AMPK / mTOR Signaling Pathway in Non-small-cell Lung Cancer

  2013cites this paper
• Aldo-Keto Reductases as New Therapeutic Targets for Colon Cancer Chemoresistance

  2013cites this paper
• Extracts of Koelreuteria henryi Dummer induce apoptosis and autophagy by inhibiting dihydrodiol dehydrogenase, thus enhancing anticancer effects.

  2013cites this paper
• Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells

  2013cites this paper
• Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest.

  2013cites this paper
• Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo

  2013cites this paper
• LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer.

  2013cites this paper
• Finding genes discriminating smokers from non-smokers by applying a growing self-organizing clustering method to large airway epithelium cell microarray data.

  2013cites this paper
• Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells.

  2012cites this paper
• Main signal pathways underlying the molecular mechanisms of the antitumor effects of wogonin

  2012cites this paper
• Anti-inflammatory changes of gene expression by Artemisia iwayomogi in the LPS-stimulated human gingival fibroblast: Microarray analysis

  2012cites this paper
• Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients.

  2012cites this paper
• Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species.

  2012cites this paper
• Dimethylarginine dimethylaminohydrolase 2, a newly identified mitochondrial protein modulating nitric oxide synthesis in normal human chondrocytes.

  2012cites this paper
• Aldo–Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers

  2011cites this paper
• Cross-kingdom actions of phytohormones: a functional scaffold exploration.

  2011cites this paper
• Caractérisation des mécanismes de résistance des cellules gliales tumorales à la chimiothérapie et identification de nouvelles pistes chimiothérapeutiques potentielles

  2011cites this paper
• Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis.

  2011cites this paper
• nhibitors of human 20-hydroxysteroid dehydrogenase ( AKR 1 C 1 )

  2011cites this paper
• Optic atrophy 1 increases cisplatin resistance via inhibition of caspase-dependent cell death

  2010cites this paper
• Identification of cisplatin‐resistance related genes in head and neck squamous cell carcinoma

  2010cites this paper
• Rationale for the Use of Natural Anti-Inflammatory Agents in Cancer Chemotherapy

  2010cites this paper
• Lung Cancer Resistance to Chemotherapy

  2010cites this paper
• Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

  2010influential citation
• Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.

  2010cites this paper